HomeCompareRYZB vs PEP

RYZB vs PEP: Dividend Comparison 2026

RYZB yields 3.20% · PEP yields 3.63%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PEP wins by $117.4K in total portfolio value· pulled ahead in Year 3
10 years
RYZB
RYZB
● Live price
3.20%
Share price
$62.49
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.6K
Annual income
$393.29
Full RYZB calculator →
PEP
PepsiCo Inc.
● Live price
3.63%
Share price
$156.82
Annual div
$5.69
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$141.9K
Annual income
$61,875.67
Full PEP calculator →

Portfolio growth — RYZB vs PEP

📍 PEP pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRYZBPEP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RYZB + PEP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RYZB pays
PEP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RYZB
Annual income on $10K today (after 15% tax)
$272.04/yr
After 10yr DRIP, annual income (after tax)
$334.30/yr
PEP
Annual income on $10K today (after 15% tax)
$308.41/yr
After 10yr DRIP, annual income (after tax)
$52,594.32/yr
At 15% tax rate, PEP beats the other by $52,260.02/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RYZB + PEP for your $10,000?

RYZB: 50%PEP: 50%
100% PEP50/50100% RYZB
Portfolio after 10yr
$83.2K
Annual income
$31,134.49/yr
Blended yield
37.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

RYZB
No analyst data
PEP
Analyst Ratings
1
Strong
15
Buy
27
Hold
1
Sell
Consensus: Hold
Price Target
$172.43
+10.0% upside vs current
Range: $156.00 — $191.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RYZB buys
0
PEP buys
0
No recent congressional trades found for RYZB or PEP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRYZBPEP
Forward yield3.20%3.63%
Annual dividend / share$2.00$5.69
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$24.6K$141.9K
Annual income after 10y$393.29$61,875.67
Total dividends collected$3.6K$123.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: RYZB vs PEP ($10,000, DRIP)

YearRYZB PortfolioRYZB Income/yrPEP PortfolioPEP Income/yrGap
1$11,020$320.05$10,849$509.42+$171.00RYZB
2$12,121$329.62$11,969$750.47+$152.00RYZB
3← crossover$13,308$338.84$13,500$1,124.14$192.00PEP
4$14,588$347.69$15,680$1,721.66$1.1KPEP
5$15,965$356.18$18,929$2,715.34$3.0KPEP
6$17,447$364.31$24,023$4,450.80$6.6KPEP
7$19,040$372.08$32,510$7,669.92$13.5KPEP
8$20,753$379.49$47,709$14,093.60$27.0KPEP
9$22,592$386.56$77,415$28,083.48$54.8KPEP
10$24,566$393.29$141,922$61,875.67$117.4KPEP

RYZB vs PEP: Complete Analysis 2026

RYZBStock

RayzeBio, Inc. develops radiopharmaceutical therapeutics (RPT) for the treatment of cancer. The company’s lead drug candidate is RYZ101, which is in phase 3 clinical trial for the treatment of gasteroenteropancreatic neuroendocrine tumors (GEP-NETs). It also develops RYZ801, a novel proprietary peptide that targets GPC3 for delivery of Ac225 for the treatment of hepatocellular carcinoma (HCC); RYZ811, a paired diagnostic imaging agent with the peptide binder, chelator, and Ga68 as the radioisotope; and a novel proprietary small molecule that targets CA9 for delivery of Ac225 for the treatment of ccRCC. The company was incorporated in 2020 and is based in San Diego, California.

Full RYZB Calculator →

PEPConsumer Staples

PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is headquartered in Purchase, New York.

Full PEP Calculator →
📬

Get this RYZB vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RYZB vs SCHDRYZB vs JEPIRYZB vs ORYZB vs KORYZB vs MAINRYZB vs MORYZB vs PMRYZB vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.